UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 219

Sortiert nach

A phase II study of combination daunorubicin, cytarabine (Ara‐c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression

American journal of hematology, 2023-03, Vol.98 (3), p.472-480

2023

Link zum Volltext

Verfügbarkeit prüfen

Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study

Bone marrow transplantation (Basingstoke), 2023-07, Vol.58 (7), p.769-776

2023

Link zum Volltext

Verfügbarkeit prüfen

Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma

Blood cancer journal (New York), 2022-07, Vol.12 (7), p.113-113, Article 113

2022

Link zum Volltext

Verfügbarkeit prüfen

Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation

Blood cancer journal (New York), 2021-03, Vol.11 (3), p.49-49, Article 49

2021

Link zum Volltext

Verfügbarkeit prüfen

Determinants of outcomes and advances in CD19‐directed chimeric antigen receptor therapy for B‐cell acute lymphoblastic leukemia

European journal of haematology, 2024-01, Vol.112 (1), p.51-63

2024

Link zum Volltext

Verfügbarkeit prüfen

Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms

Blood cancer journal (New York), 2022-07, Vol.12 (7), p.106-106, Article 106

2022

Link zum Volltext

Verfügbarkeit prüfen

66-Year-Old Woman With Falls and Confusion

Mayo Clinic proceedings, 2017-02, Vol.92 (2), p.e15-e19

2017

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma

Blood cancer journal (New York), 2021-03, Vol.11 (3), p.63-63, Article 63

2021

Link zum Volltext

Verfügbarkeit prüfen

Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome

Blood cancer journal (New York), 2023-04, Vol.13 (1), p.49-49, Article 49

2023

Link zum Volltext

Verfügbarkeit prüfen

U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity

Blood cancer journal (New York), 2023-09, Vol.13 (1), p.149-149, Article 149

2023

Link zum Volltext

Verfügbarkeit prüfen

Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma

Blood cancer journal (New York), 2023-01, Vol.13 (1), p.7-7, Article 7

2023

Link zum Volltext

Verfügbarkeit prüfen

Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma

Blood cancer journal (New York), 2022-06, Vol.12 (6), p.87-87, Article 87

2022

Link zum Volltext

Verfügbarkeit prüfen

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms

Blood cancer journal (New York), 2023-04, Vol.13 (1), p.51-51, Article 51

2023

Link zum Volltext

Verfügbarkeit prüfen

61-Year-Old Man With Right Knee Pain and Chronic Anemia

Mayo Clinic proceedings, 2016-11, Vol.91 (11), p.1640-1644

2016

Link zum Volltext

Verfügbarkeit prüfen

How do I manage refractory invasive pulmonary aspergillosis

Clinical microbiology and infection, 2024-01

2024

Link zum Volltext

Verfügbarkeit prüfen

Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study

Blood cancer journal (New York), 2021-03, Vol.11 (3), p.43-43, Article 43

2021

Link zum Volltext

Verfügbarkeit prüfen

A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome

Systematic reviews, 2018-09, Vol.7 (1), p.144-9, Article 144

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience

Blood cancer journal (New York), 2021-06, Vol.11 (6), p.122-122, Article 122

2021

Link zum Volltext

Verfügbarkeit prüfen

A novel Iowa-Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction

Blood cancer journal (New York), 2021-11, Vol.11 (11), p.183-183, Article 183

2021

Link zum Volltext

Verfügbarkeit prüfen

Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations

Current hematologic malignancy reports, 2023-10, Vol.18 (5), p.121-129

2023

Link zum Volltext

Verfügbarkeit prüfen

Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH-based algorithm distinguishes prognostic groups and outcomes

Blood cancer journal (New York), 2021-09, Vol.11 (9), p.156-156, Article 156

2021

Link zum Volltext

Verfügbarkeit prüfen

Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients

American journal of hematology, 2020-12, Vol.95 (12), p.1511-1521

2020

Link zum Volltext

Verfügbarkeit prüfen

EASIX and CPSS Cytogenetics score-based composite risk model for patients with CMML undergoing allogeneic transplant

Bone marrow transplantation (Basingstoke), 2024-04, Vol.59 (4), p.558-560

2024

Link zum Volltext

Verfügbarkeit prüfen

Venetoclax plus hypomethylating agents in DDX41-mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patients

British journal of haematology, 2024-01, Vol.204 (1), p.171-176

2024

Link zum Volltext

Verfügbarkeit prüfen

High EASIX score is an independent predictor of non-relapse mortality in patients with CMML undergoing allogeneic stem cell transplant

Bone marrow transplantation (Basingstoke), 2022-12, Vol.57 (12), p.1842-1844

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 219

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(195)
Mit Volltextzugriff
(217)

Publikationsform

Artikel
(217)
Berichte
(2)

Sprache

Englisch
(219)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(68)
Science & Technology
(68)
Hematology
(54)
Humans
(44)
Oncology
(29)
Female
(17)
Male
(17)
Middle Aged
(17)
Transplantation
(17)
Aged
(16)
Adult
(15)
Leukemia
(14)
Retrospective Studies
(14)
Immunology
(12)
Correspondence
(11)
Acute Myeloid Leukemia
(10)
Hematopoietic Stem Cell Transplantation
(10)
Leukemia, Myeloid, Acute - Genetics
(10)
Hematology, Oncology And Palliative Medicine
(9)
Mutation
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A phase II study of combination daunorubicin, cytarabine (Ara‐c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression

Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study

Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma

Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation

Determinants of outcomes and advances in CD19‐directed chimeric antigen receptor therapy for B‐cell acute lymphoblastic leukemia

Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms

66-Year-Old Woman With Falls and Confusion

Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma

Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome

U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity

Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma

Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms

61-Year-Old Man With Right Knee Pain and Chronic Anemia

How do I manage refractory invasive pulmonary aspergillosis

Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study

A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome

Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience

A novel Iowa-Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction

Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations

Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH-based algorithm distinguishes prognostic groups and outcomes

Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients

EASIX and CPSS Cytogenetics score-based composite risk model for patients with CMML undergoing allogeneic transplant

Venetoclax plus hypomethylating agents in DDX41-mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patients

High EASIX score is an independent predictor of non-relapse mortality in patients with CMML undergoing allogeneic stem cell transplant

Suchergebnisse filtern